Filter by: Subject

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (28)
Positron emission tomography (PET) (26)
Positron emission tomography/computed tomography (PET/CT) (19)
Prostate cancer (17)
Prostate-specific membrane antigen (PSMA) (13)
Tuberculosis (TB) (12)
Infection (9)
Coronavirus disease 2019 (COVID-19) (8)
COVID-19 pandemic (8)
Nuclear medicine (8)
Theranostics (8)
Human immunodeficiency virus (HIV) (6)
PET/CT (6)
South Africa (SA) (6)
Cancer (5)
Computed tomography (CT) (5)
Metastatic castration-resistant prostate cancer (mCRPC) (5)
Molecular imaging (5)
Prostate carcinoma (5)
Prostate specific membrane antigen (PSMA) (5)
Radiomics (5)
Radiopharmaceuticals (5)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (5)
Diagnosis (4)
Fluorodeoxyglucose positron emission tomography (FDG PET) (4)
HIV infection (4)
Hypoxia (4)
Patients (4)
225Ac-PSMA-617 (3)
[18F]FDG PET/CT (3)
Actinium-225 (3)
Anti-tuberculous treatment (ATT) (3)
Bacteria (3)
Cervical cancer (3)
Fibroblast activation protein (FAP) (3)
Fibroblast activation protein inhibitor (FAPI) (3)
Fluorodeoxyglucose (FDG) (3)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (3)
Health sciences article SDG-03 (3)
Invasive fungal infection (IFI) (3)
Magnetic resonance imaging (MRI) (3)
Metabolic tumor volume (MTV) (3)
PSA response (3)
Radioligand therapy (3)
Residual metabolic activity (RMA) (3)
Single-photon emission computed tomography (SPECT) (3)
Total lesion glycolysis (TLG) (3)
177Lu-PSMA (2)
18F-FDG (2)
18F-FDG PET/CT (2)
18F-fuorodeoxyglucose (FDG) (2)
68Ga-PSMA (2)
[68Ga]Ga-NODAGAZOL (2)
Angiogenesis (2)
Antimicrobial peptide (AMP) (2)
Arterial inflammation (2)
Biodistribution (2)
Bone scan (2)
Breast cancer (2)
Case report (2)
Computerized tomography (CT) (2)
Diagnostic imaging (2)
DOTA (2)
FDG PET (2)
Feature extraction (2)
HIV/AIDS (2)
Immunohistochemistry (2)
Infection imaging (2)
Inflammation (2)
Invasive fungal disease (IFD) (2)
Invasive fungal infections (2)
Medical imaging (2)
Metabolic parameters (2)
NODAGA (2)
Oncology (2)
Overall survival (OS) (2)
Patient management (2)
Principal component analysis (PCA) (2)
Prostate-specific antigen (PSA) (2)
Pulmonary tuberculosis (2)